AdCC	Adenoid cystic carcinoma
AR	Androgen receptor
CAR	Chimeric antigen receptor
CTLA-4	Cytotoxic T-lymphocyte-associated protein 4
DFS	Disease-free survival
EGFR	Epidermal growth factor receptor
HER2	Human epidermal growth factor receptor 2
HLA	Human leukocyte antigen
ICIs	Immune checkpoint inhibitors
LAG3	Lymphocyte activation gene 3
MEC	Mucoepidermoid carcinoma
NOS	Not otherwise specified
ORR	Objective response rate
OS	Overall survival
PD-1	Programmed death receptor-1
PD-L1	Programmed death ligand-1
PD-L2	Programmed death ligand-2
PFS	Progression-free survival
PSMA	Prostate-specific membrane antigen
RT	Radiation therapy
SDC	Salivary duct carcinoma
SGC	Salivary gland cancer
TAA	Tumor-associated antigen
TAM	Tumor-associated macrophage
TILs	Tumor infiltrating lymphocytes
TIM3	T-cell immunoglobulin and mucin domain-containing protein 3
TMB	Tumor mutational burden
TME	Tumor microenvironment
TSA	Tumor-specific antigen
VEGF	Vascular endothelial growth factor
WT1	Wilm’s tumor gene 1